229 related articles for article (PubMed ID: 23031078)
1. Meeting the need for regenerative therapies: translation-focused analysis of U.S. regenerative medicine opportunities in cardiovascular and peripheral vascular medicine using detailed incidence data.
Tillman B; Hardin-Young J; Shannon W; Russell AJ; Parenteau NL
Tissue Eng Part B Rev; 2013 Apr; 19(2):99-115. PubMed ID: 23031078
[TBL] [Abstract][Full Text] [Related]
2. Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation.
Udelsman BV; Maxfield MW; Breuer CK
Heart; 2013 Apr; 99(7):454-60. PubMed ID: 23363931
[TBL] [Abstract][Full Text] [Related]
3. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
[TBL] [Abstract][Full Text] [Related]
4. Theregen, inc.
Siani-Rose M
Regen Med; 2006 Nov; 1(6):841-6. PubMed ID: 17465766
[TBL] [Abstract][Full Text] [Related]
5. Technology insight: the evolution of tissue-engineered vascular grafts--from research to clinical practice.
L'Heureux N; Dusserre N; Marini A; Garrido S; de la Fuente L; McAllister T
Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):389-95. PubMed ID: 17589429
[TBL] [Abstract][Full Text] [Related]
6. [Graft or CVC? A prosthetic graft is the better choice].
Cifarelli M
G Ital Nefrol; 2009; 26(2):148-53. PubMed ID: 19382069
[TBL] [Abstract][Full Text] [Related]
7. Engineered tissue grafts: opportunities and challenges in regenerative medicine.
Feinberg AW
Wiley Interdiscip Rev Syst Biol Med; 2012; 4(2):207-20. PubMed ID: 22012681
[TBL] [Abstract][Full Text] [Related]
8. Atherothrombosis and the management of the vulnerable vascular patient.
Arora R; Rai F
Am J Ther; 2009; 16(1):24-34. PubMed ID: 19114877
[TBL] [Abstract][Full Text] [Related]
9. The economic value of investing in regenerative medicine.
Hussain A; Rivers PA
J Health Care Finance; 2009; 36(2):45-54. PubMed ID: 20499720
[TBL] [Abstract][Full Text] [Related]
10. Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts.
Cittadella G; de Mel A; Dee R; De Coppi P; Seifalian AM
Artif Organs; 2013 May; 37(5):423-34. PubMed ID: 23551257
[TBL] [Abstract][Full Text] [Related]
11. Regenerative medicine techniques in cardiovascular disease: where is the horizon?
Packer C; Boddice B; Simpson S
Regen Med; 2013 May; 8(3):351-60. PubMed ID: 23627828
[TBL] [Abstract][Full Text] [Related]
12. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
13. Enhanced external counterpulsation--a therapeutic option for patients with chronic cardiovascular problems.
Linnemeier G
J Cardiovasc Manag; 2002; 13(6):20-5. PubMed ID: 12500419
[TBL] [Abstract][Full Text] [Related]
14. Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.
Kakkos SK; Haddad GK; Haddad JA; Scully MM
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):356-65. PubMed ID: 18603454
[TBL] [Abstract][Full Text] [Related]
15. Regenerative implants for cardiovascular tissue engineering.
Lee AY; Mahler N; Best C; Lee YU; Breuer CK
Transl Res; 2014 Apr; 163(4):321-41. PubMed ID: 24589506
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs.
Kreienberg PB; Darling RC; Chang BB; Paty PS; Lloyd WE; Shah DM
J Vasc Surg; 2000 Apr; 31(4):696-701. PubMed ID: 10753277
[TBL] [Abstract][Full Text] [Related]
17. The use of prosthetic grafts in complex military vascular trauma: a limb salvage strategy for patients with severely limited autologous conduit.
Vertrees A; Fox CJ; Quan RW; Cox MW; Adams ED; Gillespie DL
J Trauma; 2009 Apr; 66(4):980-3. PubMed ID: 19359902
[TBL] [Abstract][Full Text] [Related]
18. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA
J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
20. Vascular grafts.
Leon L; Greisler HP
Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):581-94. PubMed ID: 15030257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
